NCT06415942

Brief Summary

Pregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek medical care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Dec 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Dec 2024Jan 2027

First Submitted

Initial submission to the registry

May 13, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

December 11, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Expected
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

May 13, 2024

Last Update Submit

January 14, 2026

Conditions

Keywords

pregnancy related deathpatient reported outcomesmHealthpatient activation

Outcome Measures

Primary Outcomes (1)

  • Patient activation

    Change in patient activation measured using the validated Patient Activation Measure (PAM)

    Baseline to 6 weeks postpartum

Secondary Outcomes (1)

  • Knowledge of pregnancy related death warning signs

    Baseline to 6 weeks postpartum

Study Arms (1)

MOMS intervention

EXPERIMENTAL

Participants in this condition will receive the MOMS symptom monitoring and decision support intervention. This is a single arm trial.

Other: Maternal Outcome Monitoring and Support system

Interventions

The Maternal Outcome Monitoring and Support system is a mobile health application that allows participants to choose symptoms they may be having that are warning signs of pregnancy related death. They then receive decision support about when they should seek medical care (call their provider or go to an emergency room).

MOMS intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Greater than 28 weeks pregnant
  • Receiving healthcare in the United States
  • Age 18 years or older
  • \[Identify as Black or African American race AND able to speak and read English, AND preferred language of English\] OR \[Identify as Hispanic/Latino Ethnicity AND Spanish able to speak and read Spanish AND preferred language of Spanish\]
  • Planned delivery at the following NewYork-Presbyterian hospitals: Children's Hospital of New York, Allen Hospital, Weill Cornell Medical Center, Lower Manhattan Hospital

You may not qualify if:

  • Severe cognitive impairment
  • Major psychiatric illness
  • Concomitant terminal illness that would preclude participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

NewYork-Presbyterian Columbia University Irving Medical Center

New York, New York, 10032, United States

RECRUITING

NewYork-Prebyterian/Weill Cornell Medical Center

New York, New York, 10065, United States

RECRUITING

MeSH Terms

Conditions

Maternal DeathPatient Participation

Condition Hierarchy (Ancestors)

Parental DeathDeathPathologic ProcessesPathological Conditions, Signs and SymptomsPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2024

First Posted

May 16, 2024

Study Start

December 11, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Data will be shared in the aggregate. There is no plan to make IDP available to other researchers.

Locations